Archives

by in
Entry Author Date Location
SEC Comes Calling For Aveo As FDA Panel Fallout Continues 07/11/13 Boston
FDA Declines To Approve Aveo’s Drug For Kidney Cancer 06/10/13 Boston
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
Aveo Rests Fate on Remaining Mid-Stage Trials For Cancer Drug 06/05/13 Boston
Aveo Cuts 140 Jobs As Fallout From FDA Panel Continues 06/04/13 Boston
Astellas Tells Aveo to Go It Alone in Kidney Cancer 05/24/13 Boston
Lessons For Drug Development From The Aveo Buzzsaw 05/06/13 National
East Coast Life Sciences Roundup: Aveo, Forma, Regeneron, RainDance, & More 05/03/13 Boston
Aveo Shares Plummet as FDA Advisory Panel Votes Down Cancer Drug 05/02/13 Boston
Aveo’s Stock Plunges As Day of Reckoning Nears For Cancer Drug 04/30/13 Boston
East Coast Life Sciences Roundup: Aveo, Mayo Clinic, GI Dynamics, More 01/18/13 Boston
Aveo Cuts Staff, Announces 3rd Quarter Loss 10/31/12 Boston
Aveo, Mersana, Haemonetics, & More from the Boston Life Sciences Roundup 08/03/12 Boston
Aveo Shares Fall as FDA Questions Cancer Drug Survival Trend 08/02/12 Boston
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study 05/16/12 Boston
Aveo’s Ha-Ngoc to Interview Third Rock’s Mark Levin at April 4 Forum 03/26/12 Boston
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers 01/06/12 Boston
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls 01/03/12 Boston
Nuance Buys SVOX, Aveo Sells $100M in Stock, CSN Grabs $165M, & More Boston-Area Deals News 06/22/11 Boston
Aveo Gets $100M in Stock Offering 06/15/11 Boston
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News 06/01/11 Boston
Aveo Forms $15 Million Cancer Deal With J&J Unit 05/31/11 Boston
Aveo Adds Termeer to Board, Monsanto Partners With Atlas, Biogen Drug Meets Clinical Goal, & More Boston-Area Life Sciences News 04/15/11 Boston
Genzyme’s Termeer Joins Aveo Board 04/12/11 Boston
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News 02/18/11 Boston
Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result 02/16/11 Boston
Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News 12/03/10 Boston
Aveo Pharma to Get $25M from OSI 12/01/10 Boston
Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News 10/01/10 Boston
Page 1 of 5 next page »